His family has turned to the community for monetary help to send his body back to his mother and children in Oaxaca, where they hope he will be buried.
Qlaris Bio Reports Phase 2 Clinical Trial Results Demonstrating Favorable Safety and Tolerability Profile and Positive Efficacy Signal for QLS-101 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Inozyme Pharma Reports Full Year 2021 Financial Results and Provides Business Highlights - Phase 1/2 trial of INZ-701 in adult patients with ENPP1 Deficiency underway - . | March 15, 2022
01.03.2022 - BOSTON, March 01, 2022 (GLOBE NEWSWIRE) - Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of abnormal mineralization, today announced Axel Bolte, MSc, MBA, the .